Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.165 USD | +3.68% | +11.55% | -7.23% |
18/04 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
16/04 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.23% | 2.1B | |
+9.00% | 105B | |
-0.46% | 104B | |
+5.79% | 22.94B | |
-12.74% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-8.78% | 16.96B | |
+8.27% | 14.16B | |
+39.74% | 12.63B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Earnings Flash (RXRX) RECURSION Reports Q2 Revenue $7.7M